tiprankstipranks
Trending News
More News >
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)
ASX:RMD

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Stock Statistics & Valuation Metrics

Compare
122 Followers

Total Valuation

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has a market cap or net worth of AU$49.19B. The enterprise value is AU$54.74B.
Market CapAU$49.19B
Enterprise ValueAU$54.74B

Share Statistics

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has 1.47B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1.47B
Owened by Insiders
Owened by Instutions<0.01%

Financial Efficiency

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per EmployeeAU$493,664.629
Profits Per EmployeeAU$125,120.741
Employee Count9,980
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is ―. Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value
Price to FCF
Price to Operating Cash Flow
PEG Ratio

Income Statement

In the last 12 months, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh had revenue of AU$4.93B and earned AU$1.25B in profits. Earnings per share was AU$0.84.
RevenueAU$4.93B
Gross ProfitAU$2.88B
Operating IncomeAU$1.56B
Pretax IncomeAU$1.53B
Net IncomeAU$1.25B
EBITDA1.75B
Earnings Per Share (EPS)0.84

Cash Flow

In the last 12 months, operating cash flow was AU$1.48B and capital expenditures -AU$92.51M, giving a free cash flow of AU$1.38B billion.
Operating Cash FlowAU$1.48B
Free Cash FlowAU$1.38B
Free Cash Flow per ShareAU$0.94

Dividends & Yields

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pays an annual dividend of AU$0.32, resulting in a dividend yield of 0.90%
Dividend Per ShareAU$0.32
Dividend Yield0.90%
Payout Ratio5.72%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.85
52-Week Price Change19.91%
50-Day Moving Average36.20
200-Day Moving Average35.59
Relative Strength Index (RSI)40.53
Average Volume (3m)1.51M

Important Dates

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh upcoming earnings date is Apr 23, 2025, After Close.
Last Earnings DateJan 30, 2025
Next Earnings DateApr 23, 2025
Ex-Dividend DateFeb 12, 2025

Financial Position

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has paid AU$286.27M in taxes.
Income TaxAU$286.27M
Effective Tax Rate

Enterprise Valuation

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has AU$521.94M in cash and marketable securities with AU$839.74M in debt, giving a net cash position of AU$317.79M billion.
Cash & Marketable SecuritiesAU$521.94M
Total DebtAU$839.74M
Net CashAU$317.79M
Net Cash Per ShareAU$0.22
Tangible Book Value Per Share

Margins

Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is AU$44.53, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetAU$44.53
Price Target Upside30.17%
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast10.09%
EPS Growth Forecast41.43%

Scores

Smart Score10
AI Score76
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis